Oat-Cell Carcinoma of the Prostate

2001 ◽  
Vol 67 (3) ◽  
pp. 209-212 ◽  
Author(s):  
P. López Cubillana ◽  
E. Martínez Barba ◽  
A. Prieto ◽  
G. Server Pastor ◽  
J. Sola ◽  
...  
1987 ◽  
Vol 2 (3) ◽  
pp. 151-156 ◽  
Author(s):  
Vincenzo Macchia ◽  
Angela Mariano ◽  
Mariarita Cavalcanti ◽  
Anna Coppa ◽  
Ciriaco Cecere ◽  
...  

The levels of carcinoembryonic antigeny (CEA), tissue polypeptide antigeny (TPA), CanAg 50, neuron specific enolase (NSE) and ferritin were determined in bronchial secretion and serum of patients with neoplastic and non-neoplastic lung diseases. Simultaneous determination of two or three markers in the serum and in bronchoalveolar lavage (BAL) may be clinically useful for the diagnosis of lung cancer and even for the type of tumor. The positivity of CEA determined simultaneously in serum and in BAL of patients with lung cancer is higher than 80% whereas in patients with benign lung disease it is lower than 40%. The simultaneous assay of TP A in serum and in BAL showed 100% positivity in patients with oat-cell carcinoma, the frequencies of positivity were similar in patients with non-oat-cell carcinoma. For NSE and CanAg CA-50 patients with oat-cell carinoma showed 100% positivity. Simultaneous assay of ferritin in serum and in BAL gave 85% positivity in patients with oat-cell carcinoma and only 23% in patients with non-oat-cell carcinoma. We conclude that the simultaneous determination of CEA and CanAg CA-50 or NSE in serum and in BAL is a useful aid in the diagnosis of lung malignancy.


1981 ◽  
Vol 107 (8) ◽  
pp. 506-509 ◽  
Author(s):  
C.-C. J. Sun ◽  
M. Hall-Craggs ◽  
B. Adler

2021 ◽  
Vol 23 ◽  
pp. 30-33
Author(s):  
Ryan J. Hutten ◽  
Christopher R. Weil ◽  
Jonathan D. Tward ◽  
Shane Lloyd ◽  
Skyler B. Johnson

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
C Desai ◽  
A Bhojwani ◽  
J Parkin

Abstract Introduction We report a case of small cell carcinoma of the prostate (SCCP) which is a rare, high-grade malignant neoplasm accounting for 1% of all prostate cancers (CPa). Case Presentation A 56-year-old male patient initially presented to primary care with a six-month history of frequency, nocturia and pain in the perineal region when seated. A positive family-history for CPa was noted, serum PSA was 11.58, and a rectal examination found a large, irregular mass. He was treated with antibiotics for possible prostatitis and referred to the colorectal team. MRI rectum confirmed a mass between the prostate and rectum, which was found to be pure SCCP on biopsy. Whole-body scanning found multiple lung and pelvic metastases. The patient was commenced on six cycles of Etoposide and Carboplatin therapy. The patient reported that his pelvic discomfort has improved following the first cycle. Conclusions SCCP metastasizes early and therefore the clinical presentation is often in an advanced stage. It is noted that there is limited value of serum PSA for SCCP diagnosis. Instead, pathological examinations and MRI rectum are vital. In terms of treatment, chemotherapy provides relief of the clinical symptoms and its use is in in accordance with the 2016 National Comprehensive Cancer Network guidelines.


1989 ◽  
Vol 14 (1) ◽  
pp. 75-80 ◽  
Author(s):  
F. J. PARDO MINDÁN ◽  
S. M. ALGARRA ◽  
B. R. LOZANO ◽  
R. G. TAPIA

Cancer ◽  
1978 ◽  
Vol 42 (1) ◽  
pp. 85-87 ◽  
Author(s):  
Jacob D. Bitran ◽  
Luis H. Toledo-Pereyra ◽  
Gregory Matz

BMJ ◽  
1978 ◽  
Vol 2 (6129) ◽  
pp. 10-11 ◽  
Author(s):  
F A Greco ◽  
R L Richardson ◽  
S F Schulman ◽  
S Stroup ◽  
R K Oldham

Sign in / Sign up

Export Citation Format

Share Document